ViziLite®; TBlue is designed to accurately detect abnormal lesions and rule out trauma and false positives in annual oral cancer screenings. A clinical study<sup>1</sup> has shown that the use of ViziLite TBlue after a conventional visual examination resulted in <em>no false negative outcomes</em>, proving that ViziLite TBlue identified every lesion that had precancerous or cancerous cells. The same study further proved that ViziLite TBlue also significantly reduced the number of false positive lesions identified during standard visual examinations thus limiting the number of biopsies that may have normally been performed.
ViziLite TBlue offers:
- the ability to reach all areas of the mouth
- prevention of false positives
- improved chances of detecting and diagnosis of oral cancer
Includes:
- (1) TBlue Swab
- (2) 1% Acetic Acid Swab
*Prices are subject to change without notice
